Revenio's iCare DRSplus included in FDA-cleared AI solution for diabetic retinopathy screening

Revenio's iCare DRSplus fundus imaging system is now part of the first FDA-cleared AI screening solution for diabetic retinopathy in the United States, enabling automatic detection and referral for further examination in primary care settings.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.